FDA Expands Indication of Alvotech and Teva’s Stelara Biosimilar

The expanded indication of Selarsdi for the treatment of diseases such as psoriasis, psoriatic arthritis, ulcerative colitis, and Crohn disease is expected to support the official launch early next year.